Primary liver carcinoma arising in people younger than 30 years
- PMID: 16146811
- DOI: 10.1309/TT0R7KAL32228E99
Primary liver carcinoma arising in people younger than 30 years
Abstract
Primary liver carcinomas in children and young adults are uncommon and poorly described. We examined primary liver carcinomas in people younger than 30 years and performed immunostains for markers of biliary (cytokeratin [CK] 7, CK19, CD56) and hepatocellular (HepPar) differentiation. We found 23 primary liver carcinomas were found: 13 hepatocellular carcinomas (HCCs), 9 fibrolamellar carcinomas (FLCs), and 1 cholangiocarcinoma. Most HCCs showed compact (n = 7) or trabecular (n = 4) growth patterns. The Edmondson grades were as follows: 1, 3 tumors; 2, 8 tumors; and 3, 2 tumors). All HCCs and FLCs were HepPar(+). All FLCs and 7 of 9 HCCs were CK7(+). In contrast, a control group of 65 adult HCCs showed less CK7 positivity (24 [37%]; P = .03). CK19 was positive in 2 HCCs and CD56 in 1 HCC. No chronic background liver disease was seen, although 3 cases showed foci of altered hepatocytes. HCCs are the most common primary liver carcinoma in children and young adults followed by FLCs. They are morphologically similar to adult HCC, but more likely to be CK7(+).
Comment in
-
Immunohistochemical analysis in hepatocellular carcinoma: does age matter?Am J Clin Pathol. 2005 Oct;124(4):491-3. doi: 10.1309/8W6WT3T68VMY4MV8. Am J Clin Pathol. 2005. PMID: 16146817 No abstract available.
Similar articles
-
The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.J Gastrointestin Liver Dis. 2006 Mar;15(1):9-14. J Gastrointestin Liver Dis. 2006. PMID: 16680226
-
The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.Mod Pathol. 2002 Nov;15(11):1181-90. doi: 10.1097/01.MP.0000032537.82380.69. Mod Pathol. 2002. PMID: 12429797
-
Fibrolamellar hepatocellular carcinoma: an immunohistochemical comparison with conventional hepatocellular carcinoma.Int J Surg Pathol. 2010 Oct;18(5):313-8. doi: 10.1177/1066896910364229. Epub 2010 May 5. Int J Surg Pathol. 2010. PMID: 20444731
-
Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors.Semin Liver Dis. 2011 Feb;31(1):61-70. doi: 10.1055/s-0031-1272835. Epub 2011 Feb 22. Semin Liver Dis. 2011. PMID: 21344351 Review.
-
Pathology of combined hepatocellular-cholangiocarcinoma.J Gastroenterol Hepatol. 2010 Sep;25(9):1485-92. doi: 10.1111/j.1440-1746.2010.06430.x. J Gastroenterol Hepatol. 2010. PMID: 20796144 Review.
Cited by
-
Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma.World J Gastroenterol. 2018 Sep 21;24(35):4000-4013. doi: 10.3748/wjg.v24.i35.4000. World J Gastroenterol. 2018. PMID: 30254404 Free PMC article. Review.
-
Fibrolamellar carcinoma: 2012 update.Scientifica (Cairo). 2012;2012:743790. doi: 10.6064/2012/743790. Epub 2012 Sep 23. Scientifica (Cairo). 2012. PMID: 24278737 Free PMC article. Review.
-
Functional and genetic deconstruction of the cellular origin in liver cancer.Nat Rev Cancer. 2015 Nov;15(11):653-67. doi: 10.1038/nrc4017. Nat Rev Cancer. 2015. PMID: 26493646 Review.
-
Environmental exposures as a risk factor for fibrolamellar carcinoma.Mod Pathol. 2017 Jun;30(6):892-896. doi: 10.1038/modpathol.2017.7. Epub 2017 Mar 3. Mod Pathol. 2017. PMID: 28256571
-
Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis.Case Rep Gastroenterol. 2010 May 12;4(2):144-152. doi: 10.1159/000313791. Case Rep Gastroenterol. 2010. PMID: 20805936 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous